Home › Type 2 Diabetes › North Carolina › Raleigh
Type 2 Diabetes clinical trials in Raleigh, NC
6 studies for Type 2 Diabetes are looking for participants at sites in and around Raleigh (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RecruitingPhase 3
- AURORA-2 Clinical Site, Raleigh
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
RecruitingPhase 2
- M3 Wake Research, Inc - M3 WR, Raleigh
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
RecruitingPhase 3
- Research Site, Raleigh
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
RecruitingPhase 3
- Research Site, Raleigh
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
RecruitingPhase 3
- Research Site, Raleigh
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
Recruiting
- Foot and Ankle Specialists of the Mid-Atlantic, Raleigh
About Type 2 Diabetes
Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.
More about Type 2 Diabetes on MedlinePlus
Type 2 Diabetes trials in other cities
- San Antonio, TX37 studies
- Houston, TX31 studies
- Orlando, FL24 studies
- Boston, MA20 studies
- Chicago, IL19 studies
- Miami, FL19 studies
- Dallas, TX19 studies
- Columbus, OH18 studies
- Las Vegas, NV18 studies
- Atlanta, GA17 studies
- San Diego, CA17 studies
- Los Angeles, CA16 studies
Other studies in Raleigh
- Heart Failure8 studies
- Coronary Artery Disease6 studies
- Obesity6 studies
- Macular Degeneration6 studies
- Endometrial Cancer6 studies
- Cardiovascular Disease5 studies
- Stroke5 studies
- Atherosclerosis5 studies
- Overweight5 studies
- Diabetes4 studies
- Bladder Cancer4 studies
- Geographic Atrophy4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.